Measuring Transplant Center Performance: the Goals Are Not Controversial but the Methods and Consequences Can Be

被引:55
作者
Jay C. [1 ]
Schold J.D. [2 ,3 ]
机构
[1] University Transplant Center, University of Texas Health, San Antonio, 78229, TX
[2] Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
[3] Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH
基金
美国国家卫生研究院;
关键词
Centers for Medicare and Medicaid Services; Membership and Professional Standards Committee; Organ Procurement and Transplant Network; Organ transplantation; Performance metrics; Quality; Regulatory oversight;
D O I
10.1007/s40472-017-0138-9
中图分类号
学科分类号
摘要
Purpose of Review: Risks of regulatory scrutiny has generated widespread concern about increasingly risk averse transplant center behaviors regarding both donor and candidate acceptance patterns. To address potential unintended consequences threatening access to care, we discuss recent changes in regulatory metrics and potential improvements in quality oversight of transplant centers. Recent Findings: Despite many recent changes to 1-year patient and graft survival regulatory criteria, the capacity to accurately identify true underperforming centers and avoiding false positive flagging remains an area of great concern. Numerous studies have demonstrated restrictions in transplant volume and access following transplant center flagging. Summary: Current regulatory criteria are limited in their capacity to accurately identify poorly performing centers and potentially encourage risk averse behavior by transplant centers. Efforts to address these concerns should focus on (1) improving risk adjustment models with better data which captures the acuity of candidate and donor risk, (2) reconsidering primary outcomes measured to assess comprehensive transplant center performance, (3) improving education to address rational or perceived disincentives, and (4) using data more effectively to share best practices. © 2017, Springer International Publishing AG.
引用
收藏
页码:52 / 58
页数:6
相关论文
共 32 条
[1]  
National Organ Transplantation Act Of, pp. 98-507, (1984)
[2]  
S.2946. Pub. L, Transplant Amendments Act of 1990, pp. 101-616, (1990)
[3]  
Ornstein C., Berthelson C., UCI Medical Center on Transplant Probation: Regulators impose the lesser penalty, Los Angeles Times. March, 24, (2006)
[4]  
Transplant O.C., Faulted P., Los Angeles Times, December, 28, (2005)
[5]  
Weber T., Ornstein C., Kaiser Halts Kidney Venture, Los Angeles Times. May, 13, (2006)
[6]  
Centers for Medicare and Medicaid Services, Medicare Program
[7]  
Hospital Conditions of Participation: Requirements for Approval and Re-Approval of Transplant Centers to Perform Organ Transplants, pp. 15198-15280, (2007)
[8]  
Kasiske B.L., Salkowski N., Wey A., Et al., Potential implications of recent and proposed changes in the regulatory oversight of solid organ transplantation in the United States, Am J Transplant, (2016)
[9]  
Salkowski N., Snyder J.J., Zaun D.A., Et al., A scientific registry of transplant recipients bayesian method for identifying underperforming transplant programs, Am J Transplant, 14, pp. 1310-1317, (2014)
[10]  
Abecassis M.M., Burke R., Klintmalm G.B., Et al., American Society of Transplant Surgeons transplant center outcomes requirements—a threat to innovation, Am J Transplant, 9, pp. 1279-1286, (2009)